SP Elixir (OPC) Private Limited

Imbruvica (Ibrutinib) 140mg Capsules are used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström's macroglobulinemia, and small lymphocytic lymphoma (SLL). Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor that works by blocking the action of the BTK enzyme, which is crucial for the survival and proliferation of cancerous B cells.

By inhibiting BTK, Imbruvica helps to slow the growth of these cancer cells and can significantly reduce the progression of the disease. The medication is typically taken orally, once a day, and is often used in combination with other treatments, depending on the type and stage of the cancer.

Patients using Imbruvica need regular monitoring for side effects, including infections, bleeding, heart rhythm problems, and liver function abnormalities. It is important to follow your healthcare provider's instructions carefully for optimal results.

Each capsule contains ibrutinib 140mg swallow capsule whole with water